Drägerwerk AG & Co. KGaA
General ticker "DRWKF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.2B (TTM average)
Drägerwerk AG & Co. KGaA follows the US Stock Market performance with the rate: 33.9%.
Estimated limits based on current volatility of 1.4%: low 104.25$, high 106.81$
Factors to consider:
- Earnings expected soon, date: nan
- Company pays dividends (annually): last record date 2025-05-13, amount 2.28$ (Y2.16%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [34.92$, 58.70$]
- 2025-12-31 to 2026-12-31 estimated range: [36.60$, 60.87$]
Financial Metrics affecting the DRWKF estimates:
- Negative: with PPE of 6.8 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 19.71 > 12.96
- Positive: -4.75 < Operating profit margin, % of 5.34
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.87
- Positive: Industry inventory ratio change (median), % of -1.37 <= -0.16
- Positive: 42.68 < Shareholder equity ratio, % of 49.63 <= 64.29
- Negative: negative Industry operating income (median)
- Negative: 0.73 < Interest expense per share per price, % of 3.19
- Negative: negative Industry operating cash flow (median)
Short-term DRWKF quotes
Long-term DRWKF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €3,045.23MM | €3,373.50MM | €3,370.88MM |
| Operating Expenses | €3,124.99MM | €3,189.38MM | €3,190.87MM |
| Operating Income | €-79.76MM | €184.13MM | €180.01MM |
| Non-Operating Income | €-22.65MM | €-42.81MM | €-4.62MM |
| Interest Expense | €22.62MM | €31.10MM | €27.06MM |
| R&D Expense | €343.48MM | €325.36MM | €333.07MM |
| Income(Loss) | €-102.41MM | €141.32MM | €175.39MM |
| Taxes | €-38.77MM | €29.33MM | €50.63MM |
| Profit(Loss)* | €-64.56MM | €110.43MM | €124.41MM |
| Stockholders Equity | €1,318.05MM | €1,406.78MM | €1,535.15MM |
| Inventory | €686.47MM | €648.16MM | €654.34MM |
| Assets | €3,106.58MM | €3,094.55MM | €3,093.43MM |
| Operating Cash Flow | €-144.23MM | €189.68MM | €167.31MM |
| Capital expenditure | €86.86MM | €68.21MM | €63.78MM |
| Investing Cash Flow | €36.83MM | €-67.34MM | €-43.39MM |
| Financing Cash Flow | €-29.38MM | €-154.56MM | €-161.38MM |
| Earnings Per Share** | €-3.44 | €5.89 | €6.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.